SARS-CoV-2: a storm is raging

Pedersen, Savannah F., Ho, Ya-Chi·2020·Journal of Clinical Investigation

Cited by (1,000)

Items 601–700 of 1,000

  1. Continuous renal replacement therapy and extracorporeal membrane oxygenation: implications in the COVID-19 era
    Sophia H Roberts, Matthew Lawrence Goodwin, Christopher M. Bobba, Omar H. Al-Qudsi, Sree Veena Satyapriya, Ravi S. Tripathi, Thomas John Papadimos, Bryan A. Whitson · 2021 · Perfusion
  2. Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection
    Lukas Paulsson-Habegger, Andrew K. Snabaitis, Stephen P. Wren · 2021 · Bioorganic & Medicinal Chemistry
  3. Potential and Possible Therapeutic Effects of Melatonin on SARS-CoV-2 Infection
    Evgeny Shchetinin, Владимир Александрович Батурин, Eduard Arushanyan, Albert Bolatchiev, Dmitriy Bobryshev · 2022 · Antioxidants
  4. Coagulopathy and Brain Injury Pathogenesis in Post-Covid-19 Syndrome
    Basheer Abdullah Marzoog · 2022 · Cardiovascular & Hematological Agents in Medicinal Chemistry
  5. The adverse inflammatory response of tobacco smoking in COVID-19 patients: biomarkers from proteomics and metabolomics
    Tenglong Cui, Gan Miao, Xiaoting Jin, Haiyi Yu, Ze Zhang, Liting Xu, Yili Wu, Guangbo Qu, Guoliang Liu, Yuxin Zheng et al. · 2022 · Journal of Breath Research
  6. SARS-CoV2 Infection During Pregnancy Causes Persistent Immune Abnormalities in Women Without Affecting the Newborns
    Elena Vázquez‐Alejo, Laura Tarancón‐Díez, Itzíar Carrasco, Sara Vigil‐Vázquez, Mar Muñoz-Chápuli Gutiérrez, Elena María Rincón López, Jesús Saavedra‐Lozano, María del Mar Santos Sebastián, David Aguilera‐Alonso, Alicia Hernanz‐Lobo et al. · 2022 · Frontiers in Immunology
  7. NK cell dysfunction is linked with disease severity in SARS‐CoV‐2 patients
    Khadijeh Dizaji Asl, Zeinab Mazloumi, Ghazal Majidi, Hossein Kalarestaghi, Shahnaz Sabetkam, Ali Rafat · 2022 · Cell Biochemistry and Function
  8. COVID-19-specific transcriptomic signature detectable in blood across multiple cohorts
    Tommi Välikangas, Sini Junttila, Kalle T. Rytkönen, Anu Kukkonen-Macchi, Tomi Suomi, Laura L. Elo · 2022 · Frontiers in Genetics
  9. TRPC3-Nox2 Protein Complex Formation Increases the Risk of SARS-CoV-2 Spike Protein-Induced Cardiomyocyte Dysfunction through ACE2 Upregulation
    Yuri Kato, Kazuhiro Nishiyama, Jae Man Lee, Yuko Ibuki, Yumiko Imai, Takamasa Noda, Noriho Kamiya, Takahiro Kusakabe, Yasunari Kanda, Motohiro Nishida · 2022 · International Journal of Molecular Sciences
  10. SARS-CoV-2 infection and psychiatric manifestations in a previous healthy patient.
    Noël Lorenzo-Villalba, Xavier Jannot, Anezka Syrovatkova, Vincent Michel, Emmanuel Andrès · 2020 · Europe PMC (PubMed Central)
  11. Thymidine Phosphorylase Is Increased in COVID-19 Patients in an Acuity-Dependent Manner
    Wei Li, Hong Yue · 2021 · Frontiers in Medicine
  12. Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two case reports
    Shazia Abdullah, Nihal Bashir, Nageena Mahmood · 2021 · Journal of Medical Case Reports
  13. A hydrated 2,3-diaminophenazinium chloride as a promising building block against SARS-CoV-2
    Rajani Kanta Mahato, Ayan Kumar Mahanty, Muddukrishnaiah Kotakonda, Sunnapu Prasad, Subires Bhattacharyya, Bhaskar Biswas · 2021 · Scientific Reports
  14. A benzimidazole scaffold as a promising inhibitor against SARS-CoV-2
    Prafullya Kumar Mudi, Ayan Kumar Mahanty, Muddukrishnaiah Kotakonda, Sunnapu Prasad, Subires Bhattacharyya, Bhaskar Biswas · 2022 · Journal of Biomolecular Structure and Dynamics
  15. Sensitive and specific detection of SARS-CoV-2 spike protein via plasmonic fiber-optic aptasensor
    Yanan Wang, Xiaofang Li, Meiqi Zhou, Meiqi Zhou, Yongchang Zhang, Xinxin Jin, 段延敏, Changyu Shen, Haiyong Zhu, Zhihong Li · 2025 · Sensors and Actuators B Chemical
  16. Changes in the innate immune response to SARS-CoV-2 with advancing age in humans
    Sudhanshu Agrawal, Michelle Tran, Tara Sinta Kartika Jennings, Marlaine Maged Hosny Soliman, Sally Heo, Bobby Sasson, Farah B. Rahmatpanah, Anshu Agrawal · 2024 · Immunity & Ageing
  17. Analysis of the Efficacy and Mechanism of Action of Xuebijing Injection on ARDS Using Meta‐Analysis and Network Pharmacology
    Yun Zhang, Jie Wang, Yongmei Liu, Hui Yu Yang, Guang-Jun Wu, Xuanhui He · 2021 · BioMed Research International
  18. Reducing COVID-19 Cases and Deaths by Applying Blockchain in Vaccination Rollout Management
    Jorge H. Medina, Roberto Cessa-Rojas, Vatcharapan Umpaichitra · 2021 · IEEE Open Journal of Engineering in Medicine and Biology
  19. Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future Scenarios
    Francesca Palandri, Massimo Breccia, Valerio De Stefano, Francesco Passamonti · 2021 · Cancers
  20. COVID-19 and cancer: start the resolution!
    Chantal Barksdale, Franciele Cristina Kipper, Shreya Tripathy, Selvakumar Subbian, Charles Nicholas Serhan, Dipak Panigrahy · 2022 · Cancer and Metastasis Reviews
  21. Obstetric outcomes in pregnant COVID-19 women: the imbalance of von Willebrand factor and ADAMTS13 axis
    Elvira Grandone, Antonella Vimercati, Felice Sorrentino, Donatella Colaizzo, Angelo Ostuni, Oronzo Ruggiero Ceci, Manuela Capozza, Giovanni Luca Tiscia, Antonio De Laurenzo, Mario Mastroianno et al. · 2022 · BMC Pregnancy and Childbirth
  22. Diagnostic and Therapeutic Potential for HNP-1, HBD-1 and HBD-4 in Pregnant Women with COVID-19
    Mariarita Brancaccio, Cristina Mennitti, Mariella Calvanese, Alessandro Gentile, Roberta Musto, Giulia Gaudiello, Giulia Scamardella, Daniela Terracciano, Giulia Frisso, Raffaela Pero et al. · 2022 · International Journal of Molecular Sciences
  23. In Vitro SARS-CoV-2 Infection of Microvascular Endothelial Cells: Effect on Pro-Inflammatory Cytokine and Chemokine Release
    Maria Dolci, Lucia Signorini, Sarah D’Alessandro, Federica Perego, Silvia Parapini, Michele Sommariva, Donatella Taramelli, Pasquale Ferrante, Nicoletta Basilico, Serena Delbue · 2022 · International Journal of Molecular Sciences
  24. Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction
    Rahnuma Ahmad, Mainul Haque · 2022 · Vaccines
  25. Well-differentiated liver cancers reveal the potential link between ACE2 dysfunction and metabolic breakdown
    Lise Desquilles, Luis Cano, Gevorg Ghukasyan, Nicolas Mouchet, Clémence Landreau, Anne Corlu, Bruno Clément, Bruno Turlin, Romain Désert, Orlando C. Musso · 2022 · Scientific Reports
  26. COVID-19 in patients with pre-existing chronic liver disease – predictors of outcomes
    Dinesh Walia, Anoop Saraya, Deepak Gunjan · 2023 · World Journal of Virology
  27. The pandemic COVID-19: a tale of viremia, cellular oxidation and immune dysfunction
    Adekunle Babajide Rowaiye, Olukemi Adejoke Onuh, Angus Nnamdi Oli, Okiemute Ajiroghene Okpalefe, Solomon Oluwasunmibare Oni, Ezinne Janefrances Nwonu · 2020 · Pan African Medical Journal
  28. Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?
    Gerwyn Morris, Eugene Athan, Ken R. Walder, Chiara C. Bortolasci, Adrienne E O'Neil, Wolfgang Marx, Michael Berk, Andre Ferrer Carvalho, Michael H. J. Maes, Basant K. Puri · 2020 · Life Sciences
  29. Liver disease in the era of COVID-19: Is the worst yet to come?
    Ivana Mikolašević, Dorotea Božić, Tajana Pavić, Alen Ružić, Goran Hauser, Marija Radić, Delfa Radić-Krišto, Melanija Ražov Radas, Željko Puljiz, Sandra Milić · 2021 · World Journal of Gastroenterology
  30. Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform
    Nawamin Sa-nguanmoo, K. Namdee, M. Khongkow, Uracha Ruktanonchai, Yong-Xiang Zhao, Xing-Jie Liang · 2021 · Nano Reseach
  31. Novel hit of DPP-4Is as promising antihyperglycemic agents with dual antioxidant/anti-inflammatory effects for type 2 diabetes with/without COVID-19
    Shahenda Mahgoub, Samar Said Fatahala, Amira Ibrahim Sayed, Hanaa B. Atya, Mohamed F. El Shehry, Hala Afifi, Samir M. Awad, Rania Helmy Abd El-Hameed, Heba Taha · 2022 · Bioorganic Chemistry
  32. Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions—Review of the Literature
    Săndica Bucurica, Florentina Ioniţă Radu, Ana Bucurica, Calin Socol, Ioana Prodan, Ioana Tudor, Carmen Adella Sîrbu, C Pleşa, Mariana Jinga · 2022 · Medicina
  33. Biology and Behavior of Severe Acute Respiratory Syndrome Coronavirus Contagion with Emphasis on Treatment Strategies, Risk Assessment, and Resilience
    James Baldwin, Samina Noorali, Ashok Vaseashta · 2023 · COVID
  34. TNFα rs1800629 Polymorphism and Response to Anti-TNFα Treatment in Behçet Syndrome: Data from an Italian Cohort Study
    Maria Carmela Padula, Angela Anna Padula, Salvatore D’Angelo, Nancy Lascaro, Rosa Paola Radice, Giuseppe Martelli, Pietro Leccese · 2023 · Journal of Personalized Medicine
  35. Metabolomic characteristics and related pathways in patients with different severity of COVID-19: a systematic review and meta-analysis
    Chenghao Bi, Junjie He, Yu Yuan, Sitong Che, Ting Rui Cui, Ning Li, Yubo Li, Zhiying Dou, Liwen Han · 2025 · Journal of Global Health
  36. COVID-19: benefits and risks of passive immunotherapeutics
    Ankur Gupta, Rashmi Karki, Himanshu R. Dandu, Kuldeep Dhama, Madan LB Bhatt, Shailendra Kumar Saxena · 2020 · Human Vaccines & Immunotherapeutics
  37. Why Do Immunosuppressed Patients with Inflammatory Bowel Disease Not Seem to Be at a Higher Risk of COVID-19?
    Maria Lia Scribano · 2020 · Digestive Diseases and Sciences
  38. HIV cure research in the time of COVID-19 - Antiretroviral therapy treatment interruption trials: A discussion paper
    Sarah J. Fidler, Sharon R. Lewin, Steven G. Deeks, Ole Schmeltz Søgaard, Linos Vandekerckhove, Simon Collins, D. Kelly, Jerome Amir Singh, Marina F. Caskey, John Frater · 2020 · Journal of Virus Eradication
  39. Management of acutecardiovascularevents in patients with COVID-19
    Chia‐Te Liao, Wei‐Ting Chang, Wen‐Liang Yu, Han Siong Toh · 2020 · Reviews in Cardiovascular Medicine
  40. N-acetylcysteine as a part of complex treatment of moderate COVID-associated pneumonia
    Viliya V. Gaynitdinova, Sergey Nikolaevich Avdeev, З. М. Мержоева, Zelimkhan G. M. Berikkhanov, I. V. Medvedeva, T. L. Gorbacheva · 2021 · PULMONOLOGIYA
  41. Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development
    Aleksandra Gruca, Joanna Ziemska-Legięcka, Patryk Jarnot, Elzbieta A. Sarnowska, Tomasz Jacek Sarnowski, Marcin Grynberg · 2021 · BMC Bioinformatics
  42. Evidence of SARS-CoV-2 infection in gallbladder and aggravating cholecystitis to septic shock: a case report
    Xiaopeng Hong, Jianzhong He, Peiping Li, Jiafan Chen, Baojia Zou, Zhanyu Li, Ying-Bin Jia, Ye Liu, Lukun Yang, Jian Li · 2021 · Annals of Translational Medicine
  43. Disseminated Intravascular Coagulation Score and Sepsis-induced Coagulopathy Score in Prediction of COVID-19 Severity: A Retrospective Analysis
    Mayank Kapoor, Prasan Kumar Panda, Lokesh Kumar Saini, Yogesh Arvind Bahurupi · 2021 · Indian Journal of Critical Care Medicine
  44. Combining hydroxychloroquine and minocycline: potential role in moderate to severe COVID-19 infection
    Shashank Shekhar Gautam, C S Gautam, Vivek Kumar Garg, Harmanjit Singh · 2020 · Expert Review of Clinical Pharmacology
  45. COVID-19–Associated Acute Kidney Injury and Quantified Protein Catabolic Rate: A Likely Effect of Cytokine Storm on Muscle Protein Breakdown
    Jaime Uribarri, Osama El Shamy, Shuchita Sharma, Jonathan A. Winston · 2020 · Kidney Medicine
  46. Can the hyperthermia‐mediated heat shock factor/heat shock protein 70 pathway dampen the cytokine storm during SARS‐CoV‐2 infection?
    Cédric Rébé, François Ghiringhelli, Carmen Garrido · 2020 · British Journal of Pharmacology
  47. Recent advances in materials science: a reinforced approach toward challenges against COVID-19
    Abhinav Saxena, Deepak Khare, Swati Agrawal, Angaraj Singh, Ashutosh Kumar Dubey · 2021 · Emergent Materials
  48. Ulnar Neuropathy After Intermittent Prone Positioning for COVID-19 Infection
    Michael J. Sayegh, Christopher G. Larsen, Camille Pinpin, Jessica M. Intravia, Kate W. Nellans · 2021 · JBJS Case Connector
  49. Assessment of Virological Contributions to COVID-19 Outcomes in a Longitudinal Cohort of Hospitalized Adults
    Lacy M. Simons, Ramón Lorenzo-Redondo, Meg Gibson, Sarah L. Kinch, Jacob P. Vandervaart, Nina L. Reiser, Mesut Eren, Elizabeth Lux, Elizabeth M. McNally, Anat R. Tambur et al. · 2022 · Open Forum Infectious Diseases
  50. Broad antiviral and anti‐inflammatory efficacy of nafamostat against SARS‐CoV‐2 and seasonal coronaviruses in primary human bronchiolar epithelia
    Brian F. Niemeyer, Caitlin M. Miller, Carmen Ledesma‐Feliciano, James H. Morrison, Rocío J. Jiménez-Valdés, Clarissa Clifton, Eric M. Poeschla, Kambez Hajipouran Benam · 2021 · Nano Select
  51. Age and Cytokine Gene Variants Modulate the Immunogenicity and Protective Effect of SARS-CoV-2 mRNA-Based Vaccination
    Letizia Scola, Donatella Ferraro, Giuseppa Luisa Sanfilippo, Simona De Grazia, Domenico Lio, Anna Giammanco · 2023 · Vaccines
  52. A comprehensive review of the interaction between COVID-19 spike proteins with mammalian small and major heat shock proteins
    Liberty T. Navhaya, Dzveta Mutsawashe Blessing, Mthembu Yamkela, Sesethu Godlo, Xolani Henry Makhoba · 2024 · BioMolecular Concepts
  53. Dysregulated nicotinamide adenine dinucleotide metabolome in patients hospitalized with COVID ‐19
    Rodrigo J. Valderrábano, Benjamin Wipper, Karol Mateusz Pencina, Marie E. Migaud, Yili Valentine Shang, Nancy K. Latham, Monty A Montano, James M. Cunningham, Lauren Wilson, Liming Peng et al. · 2024 · Aging Cell
  54. Dynamics of spike-specific neutralizing antibodies across five-year emerging SARS-CoV-2 variants of concern reveal conserved epitopes that protect against severe COVID-19
    Latifa Zayou, Swayam Prakash, Hawa Vahed, Nisha Rajeswari Dhanushkodi, Afshana Quadiri, Ahmed Belmouden, Zohra Lemkhente, Aziz Alami Chentoufi, Daniel Gil, Jeffrey B. Ulmer et al. · 2025 · Frontiers in Immunology
  55. The eye: “An organ that must not be forgotten in coronavirus disease 2019 (COVID-2019) pandemic”
    Sandra Carolina Durán‐Cristiano, Diana C. Mayorga G · 2020 · Journal of Optometry
  56. Potential Applications of Nanomaterials to Quench the Cytokine Storm in Coronavirus Disease 19
    Anissa Pisani, Pier Paolo Pompa, Giuseppe Bardi · 2020 · Frontiers in Bioengineering and Biotechnology
  57. Coronavirus disease-2019 (COVID-19): value of IL-6 inhibitors
    Evgeny Lvovich Nasonov · 2020 · PULMONOLOGIYA
  58. The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still’s disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles
    Luca Navarini, Marta Vomero, Damiano Currado, Onorina Berardicurti, Alice Biaggi, Annalisa Marino, Pietro Bearzi, Erika Corberi, Amelia Rigon, Luisa Arcarese et al. · 2023 · Frontiers in Immunology
  59. Obesity and Viral Infections
    Priya Jaisinghani, Rekha B. Kumar · 2023 · Gastroenterology Clinics of North America
  60. Documenting the immune response in patients with COVID-19-induced acute respiratory distress syndrome
    Junyu Lu, Xiaona Zeng, Weisheng Lu, Jihua Feng, Yegui Yang, Yongxian Wei, Yin Chen, Jianfeng Zhang, Liao Pinhu · 2023 · Frontiers in Cell and Developmental Biology
  61. Inflammation and Immune Reactions in the Fetus as a Response to COVID-19 in the Mother
    Nilufar R. Gashimova, Liudmila L. Pankratyeva, Victoria O. Bitsadze, Jamilya Kh. Khizroeva, Maria V. Tretyakova, Kristina N. Grigoreva, Valentina I. Tsibizova, Jean‐Christophe Gris, N.D. Degtyareva, F. E. Yakubova et al. · 2023 · Journal of Clinical Medicine
  62. Increased Metabolic Burden Among Blacks: A Putative Mechanism for Disparate COVID-19 Outcomes
    Girardin Jean‐Louis, Arlener D. Turner, Peng Jin, Mengling Liu, Carla Boutin‐Foster, Samy I. McFarlane, Azizi A Seixas · 2020 · Diabetes Metabolic Syndrome and Obesity
  63. NFATc3 regulation of collagen V expression contributes to cellular immunity to collagen type V and hypoxic pulmonary hypertension
    Joshua R. Sheak, David T Jones, Benjamin J. Lantz, Levi D. Maston, Danielle Vigil, Thomas C. Resta, Micaela M. Resta, Tamara A. Howard, Nancy Lapp Kanagy, Yan Ping Guo et al. · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  64. What Is a Cytokine Storm and Should It Matter to Me?
    Jennifer Simkin, Tierra Strange, Nicholas Leblanc, Jessica C. Rivera · 2021 · Journal of the American Academy of Orthopaedic Surgeons
  65. COVID-19 associated thromboinflammation of renal capillary: potential mechanisms and treatment.
    Xiaojing Chen, Chengyuan Yu, Haijiao Jing, Chunxu Wang, Xinyi Zhao, Jinming Zhang, Shuoqi Zhang, Huan Liu, Rujuan Xie, Jialan Shi · 2020 · Europe PMC (PubMed Central)
  66. A Case Series of Severe Hospitalized COVID-19 Patients Treated with Tocilizumab and Glucocorticoids: A Report from Saudi Arabian Hospital
    Salma AlBahrani, Jaffar A. Al‐Tawfiq, Abdulaziz Alshaer, Amal Shilash, Khalid Alswefy, Razan Salamah Al-Zayer, Amr Abouelela · 2021 · Journal of Epidemiology and Global Health
  67. Covid 19-the 21st Century Pandemic: The Novel Coronavirus Outbreak and the Treatment Strategies
    Sherin John Joseph, Anila Kutty Narayanan · 2021 · Advanced Pharmaceutical Bulletin
  68. COVID-19: imbalance of multiple systems during infection and importance of therapeutic choice and dosing of cardiac and anti-coagulant therapies
    Habib Haybar, Mahmood Maniati, Najmaldin Saki, Zeinab Deris Zayeri · 2021 · Molecular Biology Reports
  69. Characteristics of Impaired Chemosensory Function in Hospitalized COVID-19 Patients
    Mattis Bertlich, Clemens Stihl, Bernhard G. Weiss, Martin Canis, Frank Haubner, Friedrich Ihler · 2020 · SSRN Electronic Journal
  70. Asthma and COVID-19: a controversial relationship
    Carlos Dounce, Angélica Flores–Flores, Mariana S Bazán, Victor Portales-Rivera, Araceli A Morelos-Ulíbarri, Blanca Margarita Bazan-Perkins · 2023 · Virology Journal
  71. Helminth Coinfections Modulate Disease Dynamics and Vaccination Success in the Era of Emerging Infectious Diseases
    Brice Armel Nembot Fogang, Linda Batsa Debrah, Michael Owusu, George Agyei, Julia Meyer, Jonathan Mawutor Gmanyami, Manuel Ritter, Kathrin Arndts, Derrick Adu Mensah, Tomabu Adjobimey et al. · 2025 · Vaccines
  72. Management strategies for patients with autoimmune diseases during the COVID-19 pandemic: A perspective from China
    Yu Liu Liu, Christopher Chia-Chi Chang, Qianjin Lu · 2020 · European Journal of Rheumatology
  73. Mast Cell Tryptase and Implications for SARS-CoV-2 Pathogenesis
    Negar Karimi, Solmaz Morovati, Lily Chan, Christina Napoleoni, Yeganeh Mehrani, Byram W. Bridle, Khalil Karimi · 2021 · BioMed
  74. Remote management of osteoporosis in the first wave of the COVID-19 pandemic
    Gianmaria Salvio, Claudio Gianfelice, Francesca Firmani, Stefano Lunetti, Rossella Ferroni, Giancarlo Balercia, Gilberta Giacchetti · 2022 · Archives of Osteoporosis
  75. Identification of genomic determinants contributing to cytokine release in immunotherapies and human diseases
    Lipei Shao, Alejandra Pelayo, Rongye Shi, Jinxia Ma, Hui Liu, Yihua Cai, Michaela Procházková, Robert P. T. Somerville, Sandhya Ramanathan Panch, Nirali N. Shah et al. · 2022 · Journal of Translational Medicine
  76. Pathophysiological conditions induced by SARS-CoV-2 infection reduce ACE2 expression in the lung
    Yoko Miura, Hirotsugu Ohkubo, Akiko Nakano, Jane Elizabeth Bourke, Satoshi Kanazawa · 2022 · Frontiers in Immunology
  77. Stimulation of interferon-β responses by aberrant SARS-CoV-2 small viral RNAs acting as retinoic acid-inducible gene-I agonists
    Yasuha Arai, Itaru Yamanaka, Toru Okamoto, Ayana Isobe, Naomi Nakai, Naoko Kamimura, Tatsuya Suzuki, Tomo Daidoji, Takao Ono, Takaaki Nakaya et al. · 2022 · iScience
  78. The pattern of cytokines expression and dynamic changes of renal function at 6 months in patients with Omicron COVID‐19
    Lanbo Teng, Xinyuan Song, Miaomiao Zhang, Yingying Han, Chang Ge, Wenxiu Chang, Zhongyang Shen · 2023 · Journal of Medical Virology
  79. Differential immunometabolic responses to Delta and Omicron SARS-CoV-2 variants in golden syrian hamsters
    Rajesh Rajaiah, Kabita Pandey, Arpan Acharya, Anoop T. Ambikan, Narendra Kumar, Reema S. Guda, Sean N. Avedissian, Luis J. Montaner, Samuel M. Cohen, Ujjwal Neogi et al. · 2024 · iScience
  80. Immune Dysfunction and Multiple Treatment Modalities for the SARS-CoV-2 Pandemic: Races of Uncontrolled Running Sweat?
    Ashish Kothari, Vanya Singh, Uttam Kumar Nath, Sandeep Kumar, Vineeta Rai, Karanvir Kaushal, Balram Ji Omar, Atul Pandey, Neeraj Kumar Jain · 2020 · Biology
  81. Statistical design of Phase II/III clinical trials for testing therapeutic interventions in COVID-19 patients
    Shesh Nath Rai, Chen Qian, Jianmin Pan, Anand K. Seth, Deo Kumar Srivastava, Aruni Bhatnagar · 2020 · BMC Medical Research Methodology
  82. On the role of bacterial metalloproteases in COVID-19 associated cytokine storm
    László Földvári-Nagy, Tamás Schnabel, Gabriella Dörnyei, Tamas Douglas Korcsmaros, Katalin Lenti · 2021 · Cell Communication and Signaling
  83. The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19
    Shrey Dwivedi, Princy Choudhary, Ayushi Gupta, Sangeeta Singh · 2022 · Critical Reviews in Microbiology
  84. Inhibition of a broad range of SARS-CoV-2 variants by antiviral phytochemicals in hACE2 mice
    Eun-Ha Kim, Ba-Wool Lee, Byeol Ryu, Hyo Moon Cho, Se‐Mi Kim, Seung‐Gyu Jang, Mark Anthony B. Casel, Rare Rollon, Ji‐Seung Yoo, Haryoung Poo et al. · 2022 · Antiviral Research
  85. Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients
    Betül Çavuşoğlu Türker, Fatih Türker, Süleyman Ahbab, Emre Hoca, Ayşe Öznur Urvasızoğlu, Seher Irem Cetin, Hayriye Esra Ataoğlu · 2022 · International Journal of General Medicine
  86. Elovanoid-N32 or RvD6-isomer decrease ACE2 and binding of S protein RBD after injury or INFγ in the eye
    Thang L. Pham, Jiucheng He, Azucena H Kakazu, Jorgelina M. Calandria, Khanh V. Do, Robert Nshimiyimana, Nicos A. Petasis, Haydee E. P. Bazán, Nicolas Guillermo Bazan · 2020
  87. A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster Model
    Swayam Prakash, Nisha Rajeswari Dhanushkodi, Mahmoud Singer, Afshana Quadiri, Latifa Zayou, Hawa Vahed, Pierre-Gregoire A. Coulon, Izabela Coimbra Ibraim, Christine Tafoya, Lauren Hitchcock et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  88. Neutrophil-Lymphocyte Ratio Predicting Case Severity in SARS-CoV-2 Infection: A Review
    Sonal Agarwal · 2022 · Cureus
  89. Different cytokine and chemokine profiles in hospitalized patients with COVID-19 during the first and second outbreaks from Argentina show no association with clinical comorbidities
    Laura Almada, Sofia Carla Angiolini, Nicolás Daniel Dho, Jeremías Dutto, Yamila Gazzoni, Clarisa Manzone-Rodríguez, Constanza Marín, Nicolás Eric Ponce, Daniela Soledad Arroyo, Juan N. Quiroz et al. · 2023 · Frontiers in Immunology
  90. Mitigating neutrophil trafficking and cardiotoxicity with DS–IkL in a microphysiological system of a cytokine storm
    Venktesh S. Shirure, Sergey Yechikov, Bhupinder S. Shergill, Tima Dehghani, Anton V. Block, Harkanwalpreet Sodhi, Alyssa Panitch, Steven C. George · 2023 · Lab on a Chip
  91. COVID-19 pneumonia: increased choline uptake with 18F-choline PET/CT
    Laura Olivari, Niccolò Riccardi, Paola Rodari, Andrea Angheben, Paolo Artioli, Matteo Salgarello · 2020 · European Journal of Nuclear Medicine and Molecular Imaging
  92. Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions
    Anil Kumar Sharma, Varruchi Sharma, Sharma Arun, Suresh Pallikkuth, Anil Kumar Sharma · 2020 · Current Medicinal Chemistry
  93. Antibody Response to Severe Acute Respiratory Syndrome‐ Corona Virus 2, Diagnostic and Therapeutic Implications
    Yuval Ishay, Asa Kessler, Asaf Schwarts, Yaron Ilan · 2020 · Hepatology Communications
  94. The Dynamic Expression of Potential Mediators of Severe Acute Respiratory Syndrome Coronavirus 2 Cellular Entry in Fetal, Neonatal, and Adult Rhesus Monkeys
    Bangrong Cao, Liping Zhang, Huifen Liu, Shiqi Ma, Kun Mi · 2021 · Frontiers in Genetics
  95. Immunomodulation and immunotherapeutics of COVID-19
    Sourbh Suren Garg, Atulika Sharma, Jeena Gupta · 2021 · Clinical Immunology
  96. COVID-19 and fertility—at the crossroads of autoimmunity and thrombosis
    Javeria Tariq, Tulika Chatterjee, Laura Andréoli, Latika Gupta · 2021 · Rheumatology International
  97. Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions
    Priyanka Saha, Subhankar Bose, Amit Kumar Srivastava, Anis Ahmad Chaudhary, Rajiv Lall, Sahdeo Prasad · 2021 · Molecules
  98. Exploring extracellular vesicles as mediators of clinical disease and vehicles for viral therapeutics: Insights from the COVID-19 pandemic
    Vaughn D. Craddock, Christine M. Cook, Navneet Kaur Dhillon · 2022 · Extracellular Vesicles and Circulating Nucleic Acids
  99. Is SARS-CoV-2 a Risk Factor of Bipolar Disorder?—A Narrative Review
    Piotr Lorkiewicz, Napoleon Waszkiewicz · 2022 · Journal of Clinical Medicine
  100. Inflammation in COVID-19: A Risk for Superinfections
    Mariana Boulos, Tamara Bassal, Layyous Asad, Maamoun Basheer, Nimer Assy · 2022 · COVID